Establishment Labs Holdings ROE 2017-2018 | ESTA

Current and historical return on equity (ROE) values for Establishment Labs Holdings (ESTA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Establishment Labs Holdings ROE for the three months ending September 30, 2018 was -173.53%.
Establishment Labs Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $-0.02B $0.08B -110.77%
2018-06-30 $-0.03B $0.00B 1000.00%
2018-03-31 $-0.04B $-0.01B 1057.14%
2017-12-31 $-0.04B $-0.01B 2800.00%
2017-09-30 $-0.03B $0.00B 430.77%
Sector Industry Market Cap Revenue
Medical Medical Services $0.485B $0.035B
Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Express Scripts Holding (ESRX) United States $55.382B 11.45
ICON (ICLR) Ireland $7.220B 22.63
PRA Health Sciences (PRAH) United States $6.479B 26.45
Charles River Laboratories (CRL) United States $6.010B 21.07
Premier (PINC) United States $5.056B 17.16
INC Research Holdings (SYNH) United States $4.514B 18.22
HealthEquity (HQY) United States $3.874B 75.72
Teladoc (TDOC) United States $3.587B 0.00
NovoCure (NVCR) Jersey $3.317B 0.00
AMN Healthcare Services Inc (AMN) United States $2.641B 18.12
BioTelemetry (BEAT) United States $2.149B 37.96
Medpace Holdings (MEDP) United States $1.902B 23.53
IKang Healthcare (KANG) China $1.412B 70.10
Intrexon (XON) United States $1.138B 0.00
Healthways (TVTY) United States $1.070B 13.16
CareDx (CDNA) United States $1.067B 0.00
Natera (NTRA) United States $0.946B 0.00
China Cord Blood (CO) China $0.729B 20.00
Surgery Partners (SGRY) United States $0.612B 0.00
Apollo Medical Holdings (AMEH) United States $0.582B 0.00
Civitas Solutions (CIVI) United States $0.532B 9.66
OncoCyte (OCX) United States $0.061B 0.00
Interpace Diagnostics (IDXG) United States $0.029B 0.00
Cancer Genetics (CGIX) United States $0.015B 0.00
OpGen (OPGN) United States $0.008B 0.00
FORM Holdings (XSPA) United States $0.005B 0.00
Biocept (BIOC) United States $0.002B 0.00